C01G9/04

Basic zinc chloride particulate matter and preparation method therefor

A basic zinc chloride particulate matter and a preparation method therefor. The basic zinc chloride particulate matter mainly consists of basic zinc chloride particles. In the basic zinc chloride particulate matter, D.sub.10>100 μm, and D.sub.95>450 μm. The basic zinc chloride particles do not contain adhesives. The basic zinc chloride particles contained in the basic zinc chloride particulate matter are approximately spherical, and the basic zinc chloride particles with the particle diameter>500 μm in the basic zinc chloride particulate matter accounts for 1% or less of the total mass of the basic zinc chloride particulate matter.

BIODEGRADABLE POLYMER FORMULATIONS FOR EXTENDED EFFICACY OF BOTULINUM TOXIN

Methods for the formulation of biodegradable microparticles for delivery of protein drugs, such as botulinum toxin, have been developed. The methods include the steps of precipitating and washing proteins with organic solvent to remove water prior to dispersing in polymer-dissolved organic solvent to prevent exposure to water/solvent interfaces and maintain bioactivity of the protein drugs and fabrication of microparticles by either template or emulsion method. Biodegradable microparticles, formed of one or more biodegradable polymers having entrapped in the polymer one or more protein agents, such as botulinum toxin, are also provided. Precipitated botulinum toxin and botulinum toxin-loaded microparticles can also be formulated into thermogels or crosslinked hydrogels. The stability of the protein within these microparticles, as well as the controlled release of the entrapped agents, provides for sustained efficacy of the agents.

BIODEGRADABLE POLYMER FORMULATIONS FOR EXTENDED EFFICACY OF BOTULINUM TOXIN

Methods for the formulation of biodegradable microparticles for delivery of protein drugs, such as botulinum toxin, have been developed. The methods include the steps of precipitating and washing proteins with organic solvent to remove water prior to dispersing in polymer-dissolved organic solvent to prevent exposure to water/solvent interfaces and maintain bioactivity of the protein drugs and fabrication of microparticles by either template or emulsion method. Biodegradable microparticles, formed of one or more biodegradable polymers having entrapped in the polymer one or more protein agents, such as botulinum toxin, are also provided. Precipitated botulinum toxin and botulinum toxin-loaded microparticles can also be formulated into thermogels or crosslinked hydrogels. The stability of the protein within these microparticles, as well as the controlled release of the entrapped agents, provides for sustained efficacy of the agents.

Divalent brine fluids having improved rheology and multifunctional properties

A method of improving rheological properties of a divalent brine based downhole treatment fluid at an elevated temperature comprises adding to the divalent brine based downhole treatment fluid a rheological modifier, which comprises a carboxylic acid ester, or a phosphate ester blended with an ethoxylated glycol, or a combination comprising at least one of the foregoing in an amount effective to improve the rheological properties of the divalent brine based downhole treatment fluid at a temperature of greater than about 200° F. The divalent brine based downhole treatment fluid comprises calcium bromide, calcium chloride, zinc bromide, zinc chloride, or a combination comprising at least one of the foregoing.

Divalent brine fluids having improved rheology and multifunctional properties

A method of improving rheological properties of a divalent brine based downhole treatment fluid at an elevated temperature comprises adding to the divalent brine based downhole treatment fluid a rheological modifier, which comprises a carboxylic acid ester, or a phosphate ester blended with an ethoxylated glycol, or a combination comprising at least one of the foregoing in an amount effective to improve the rheological properties of the divalent brine based downhole treatment fluid at a temperature of greater than about 200° F. The divalent brine based downhole treatment fluid comprises calcium bromide, calcium chloride, zinc bromide, zinc chloride, or a combination comprising at least one of the foregoing.

Intrinsic CO2 capture process for the production of metal oxides, cement, CO2 air capture or a combination thereof
11034619 · 2021-06-15 · ·

The present invention pertains to a process for producing captured carbon dioxide. Calcium carbonate may be reacted with sulfur dioxide to produce calcium sulfite and gaseous carbon dioxide. Calcium sulfite may be thermally decomposed to produce gaseous sulfur dioxide. The processes may be used in conjunction with combusting various fuels such as a carbonaceous fuel, or a sulfurous fuel, or a nitrogenous fuel, or a hydrogen fuel, or a combination thereof.

BIODEGRADABLE POLYMER FORMULATIONS FOR EXTENDED EFFICACY OF BOTULINUM TOXIN

Methods for the formulation of biodegradable microparticles for delivery of protein drugs, such as botulinum toxin, have been developed. The methods include the steps of precipitating and washing proteins with organic solvent to remove water prior to dispersing in polymer-dissolved organic solvent to prevent exposure to water/solvent interfaces and maintain bioactivity of the protein drugs and fabrication of microparticles by either template or emulsion method. Biodegradable microparticles, formed of one or more biodegradable polymers having entrapped in the polymer one or more protein agents, such as botulinum toxin, are also provided. Precipitated botulinum toxin and botulinum toxin-loaded microparticles can also be formulated into thermogels or crosslinked hydrogels. The stability of the protein within these microparticles, as well as the controlled release of the entrapped agents, provides for sustained efficacy of the agents.

BIODEGRADABLE POLYMER FORMULATIONS FOR EXTENDED EFFICACY OF BOTULINUM TOXIN

Methods for the formulation of biodegradable microparticles for delivery of protein drugs, such as botulinum toxin, have been developed. The methods include the steps of precipitating and washing proteins with organic solvent to remove water prior to dispersing in polymer-dissolved organic solvent to prevent exposure to water/solvent interfaces and maintain bioactivity of the protein drugs and fabrication of microparticles by either template or emulsion method. Biodegradable microparticles, formed of one or more biodegradable polymers having entrapped in the polymer one or more protein agents, such as botulinum toxin, are also provided. Precipitated botulinum toxin and botulinum toxin-loaded microparticles can also be formulated into thermogels or crosslinked hydrogels. The stability of the protein within these microparticles, as well as the controlled release of the entrapped agents, provides for sustained efficacy of the agents.

Biodegradable polymer formulations for extended efficacy of botulinum toxin

Methods for the formulation of biodegradable microparticles for delivery of protein drugs, such as botulinum toxin, have been developed. The methods include the steps of precipitating and washing proteins with organic solvent to remove water prior to dispersing in polymer-dissolved organic solvent to prevent exposure to water/solvent interfaces and maintain bioactivity of the protein drugs and fabrication of microparticles by either template or emulsion method. Biodegradable microparticles, formed of one or more biodegradable polymers having entrapped in the polymer one or more protein agents, such as botulinum toxin, are also provided. Precipitated botulinum toxin and botulinum toxin-loaded microparticles can also be formulated into thermogels or crosslinked hydrogels. The stability of the protein within these microparticles, as well as the controlled release of the entrapped agents, provides for sustained efficacy of the agents.

Biodegradable polymer formulations for extended efficacy of botulinum toxin

Methods for the formulation of biodegradable microparticles for delivery of protein drugs, such as botulinum toxin, have been developed. The methods include the steps of precipitating and washing proteins with organic solvent to remove water prior to dispersing in polymer-dissolved organic solvent to prevent exposure to water/solvent interfaces and maintain bioactivity of the protein drugs and fabrication of microparticles by either template or emulsion method. Biodegradable microparticles, formed of one or more biodegradable polymers having entrapped in the polymer one or more protein agents, such as botulinum toxin, are also provided. Precipitated botulinum toxin and botulinum toxin-loaded microparticles can also be formulated into thermogels or crosslinked hydrogels. The stability of the protein within these microparticles, as well as the controlled release of the entrapped agents, provides for sustained efficacy of the agents.